A step-by-step roll-up playbook for acquiring independent orthopedic clinics in the highly fragmented $67B U.S. musculoskeletal services market.
Find Orthopedic Clinic Platform TargetsThe U.S. orthopedic services market remains highly fragmented, with thousands of independent single- and multi-physician practices generating $1M–$10M EBITDA. PE-backed consolidators and physician management groups are acquiring these practices at 4–7x EBITDA, centralizing back-office operations, layering ancillary revenue, and exiting at 8–12x on a scaled platform basis.
Independent orthopedic clinics struggle with administrative burden, payer contract leverage, and succession risk. Roll-up buyers capture multiple arbitrage by acquiring at 4–5x and exiting at 8–12x, while creating durable competitive advantages through shared imaging, physical therapy, and ASC ownership across a regional network.
Minimum $1.5M EBITDA
Platform acquisition must generate at least $1.5M in verified EBITDA with accrual-based financials and clean billing documentation to support institutional financing and add-on acquisition capacity.
3+ Physicians on Staff
Minimum three credentialed orthopedic surgeons reduces key-man concentration risk and provides clinical depth to absorb patient volume from future add-on acquisitions without capacity constraints.
40%+ Commercial Payer Mix
Strong commercial insurance concentration ensures favorable reimbursement rates per CPT code, supporting healthy EBITDA margins and reducing exposure to CMS rate compression affecting Medicare-heavy practices.
In-House Ancillary Services
Existing physical therapy, diagnostic imaging, or DME operations provide immediate diversified revenue and serve as the infrastructure template for standardizing ancillary services across all acquired add-on clinics.
Single- or Two-Physician Clinics
Solo and small-group orthopedic practices with $500K–$1.5M EBITDA are ideal add-ons — priced at 3–5x and easily absorbed into the platform's existing payer contracts, credentialing, and administrative infrastructure.
Complementary Geographic Markets
Target clinics within 30–60 miles of the platform to enable shared administrative staff, cross-referrals, and consolidated payer contract negotiations without cannibalizing existing patient volume.
Sports Medicine or Spine Subspecialty
Add-ons with distinct subspecialties — sports medicine, spine, or joint replacement — broaden the platform's clinical service offering and strengthen referral relationships with ERs, employers, and primary care networks.
Retiring Physician Motivated Sellers
Physicians aged 55–70 without succession plans accept lower multiples and favorable earnout structures, reducing acquisition cost while ensuring clinical continuity through negotiated employment agreements post-close.
Build your Orthopedic Clinic roll-up
DealFlow OS surfaces off-market Orthopedic Clinic targets with seller signals — the foundation of every successful roll-up.
Centralized Back-Office and Revenue Cycle Management
Consolidate billing, coding, credentialing, and payer contract negotiation across all clinics under a single MSO to reduce administrative overhead and improve net collections rate by 8–15%.
Ancillary Revenue Expansion
Deploy in-house physical therapy, MRI, and DME at every acquired location to capture downstream revenue currently lost to third-party providers, adding high-margin ancillary revenue without proportional cost increases.
Payer Contract Leverage
Renegotiate commercial payer contracts across the consolidated network to secure volume-based rate increases of 10–20% above individual clinic rates, directly expanding EBITDA margins at minimal incremental cost.
Ambulatory Surgery Center Development or Partnership
Establish or acquire ASC ownership stakes to capture facility fee revenue on outpatient surgical cases, shifting high-margin procedures from hospital settings to the platform's own infrastructure.
A scaled orthopedic platform with $8M–$15M EBITDA, diversified physician base, in-house ancillaries, and regional payer dominance typically attracts strategic buyers or larger PE sponsors at 8–12x EBITDA. Ideal exit horizon is 4–6 years post-platform acquisition, targeting hospital systems, national physician management groups, or secondary PE buyouts.
A Management Services Organization separates the clinical entity from business operations, enabling non-physician investors to own the MSO while contracted physicians maintain licensure and clinical control, satisfying corporate practice of medicine regulations in most states.
Engage healthcare regulatory counsel on every transaction to structure physician compensation, ancillary referrals, and ASC ownership under recognized Stark Law exceptions such as the in-office ancillary services exception and bona fide employment arrangements.
Physician key-man risk is the primary threat. Mitigate it through multi-year employment agreements, competitive compensation benchmarked to MGMA data, and non-compete covenants tied to earnout payments that align surgeon incentives with platform performance.
Yes. SBA 7(a) loans up to $5M are commonly used for individual clinic acquisitions. Most sponsors combine SBA financing with a 10–15% seller note and earnout tied to physician retention and revenue thresholds to minimize equity required at close.
More Orthopedic Clinic Guides
DealFlow OS surfaces off-market platform targets with seller motivation scores. Free to join.
Find platform targets — freeNo credit card required
For Buyers
For Sellers